Skip to main content
Clinical Trials/TCTR20201125006
TCTR20201125006
Completed
Phase 4

An intravenous Lidocaine bolus for reducing pain from intravenous Nefopam infusion

none0 sites42 target enrollmentNovember 25, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
pain from nefopam injection
Sponsor
none
Enrollment
42
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 25, 2020
End Date
October 6, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • General Patient age 20\-80 years old who was schedile for an elective surgery at King Chulalongkorn Memorial Hospital with a plan for regional anesthesia (Neuraxial/peripheral anesthesia)

Exclusion Criteria

  • 1\.Patient allergy to any medication used in the study
  • 2\.Patient unable to state or understand VAS score
  • 3\.Patient who had previous experience with nefopam
  • 4\.Patient with Chronic pain
  • 5\.Patient who was having medication which increase Serotonin level

Outcomes

Primary Outcomes

Not specified

Similar Trials